News Focus
News Focus
Post# of 257257
Next 10
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

Re: nuere post# 68601

Sunday, 11/16/2008 1:04:39 AM

Sunday, November 16, 2008 1:04:39 AM

Post# of 257257
Late-Stage Products Looking for a Home

Criteria for inclusion:
a) Program is in phase-3 or beyond and is non-partnered.
b) Company does not have enough cash to bring the product to market.

Edits: DYAX, Pharming.
 
Stock Product Stage Comments
----- --------------- --------------------- -----------------------------
BPAX Libigel Phase 3 ~2010 Submit Adequate Safety?
CHTP Droxidopa Pivotal Phase III Orthostatic hypotension. Results expected 02/09.
DYAX DX-88 for HAE BLA filed 9/24/08 (CABG indication partnered w CBST)
EPIX Vasovist PDUFA 12/30/08 FDA initially rejected saying 2 more studies needed. Looking to sell outright on approval.
GNVC TNFerade Pivotal Phase III Pancreatic cancer
JAV Dyloject Phase III Approved in UK. Post operative Pain (injectable)
JAV Ketamine Phase III Acute moderate-to-severe pain (intranasal)
NTII Viprinex Phase 3 Interim analysis January '09. Stroke Drug, high chance of failure.
OXGN Zybrestat Phase 3 Anaplastic thyroid cancer
Pharming Rhucin Pre-BLA Rejected in EU
RPRX Proellex Phase 3 Uterine fibroids

Procedure for Updating Table

1. Copy the text in this post into a word processor.

2. Using a monospace font (e.g. Courier) to facilitate tabular
alignment, make your additions and modifications, inserting
them in the table in alphabetical order. NOTE: use spaces
rather than tab characters.

3. Add a brief note in the “Edits:” line atop the table to
describe your changes.

4. Insert the iHub formatting directives: Put [ pre ] at the
beginning of the table without the surrounding spaces, and
put [ /pre ] at the end of the table without the surrounding
spaces.

5. Post your text as a reply to this message.

Thank you for your cooperation.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today